The National Cancer Center said Tuesday its researchers confirmed that two elderly patients with diffuse large B-cell lymphoma in complete remission after combined immunochemotherapy developed the Guillain-Barré syndrome after receiving Pfizer–BioNTech Covid-19 vaccines.Guillain-Barré syndrome is a
CHA University Professor Lim Dae-seog and his life science-bio engineering team have transferred its technology on Parkinson's disease treatment using dendritic cells to Pharos Vaccine, a cell therapy developer.Under the accord, Pharos Vaccine will pay 1 billion won ($843,000) to the CHA University'
Daewoong Pharmaceutical is seeking to expand the indication of Easyef Oint., a wound ointment containing epidermal growth factor (EGF), to treat adverse skin reactions in cancer patients shown after the use of epidermal growth factor receptor (EGFR) inhibitors such as erlotinib.On Monday, the Minist
The health status of doctors and nurses was worse than that of the general population, a Korean medical report showed. For example, a larger share of doctors and nurses died from heart disease and suffered from stress-induced gastritis than the general public.A joint research team, led by the Preven
The government decided Monday to exempt shopping malls and theaters from its vaccine pass system, causing restaurant and café owners to protest against what they saw as an “uneven” vaccine mandate policy.The government decided to halt vaccine pass requirements at department stores, supermarkets, cra
Researchers at Seoul National University Hospital (SNUH) have developed an AI platform using objective and biological indicators based on magnetic resonance imaging (MRI) brain images to diagnose autism spectrum disorder (ASD) rapidly and accurately.ASD is a neurodevelopmental disorder that affects
inno.N's gastroesophageal reflux disease (GERD) therapy, K-CAB, has become a blockbuster drug by surpassing annual sales of 100 billion won ($83.8 million) in just three years of its launch, the fastest among homegrown treatments.K-CAB’s outpatient prescription totaled 109.6 billion won last year, e
The government’s recognition of MSD’s Keytruda (pembrolizumab) for reimbursement as the first-line therapy for lung cancer has accelerated the company’s development of another oncology pipeline built from the backbone of Keytruda.On Friday, the Ministry of Food and Drug Safety authorized MSD to cond
ImmuneOncia Therapeutics said on Monday that it raised 24.5 billion won ($20.5 million) pre-IPO funds.Earlier in 2019, the company attracted 45 billion won investment from Paratus Investment, a private-equity firm.Before going public, ImmuneOncia raised 70 billion won in total.Yuhan Corp., the large
GC said it has launched Pojinen cream, a compound treatment for recurrent herpes labialis.Herpes labialis is a disease caused by infection with the herpes virus, which remains in the body for life. The virus is usually dormant but becomes active when the immune system weakens, causing blisters, itch
Gemvax & KAEL said that it had received approval from the Ministry of Food and Drug Safety for a phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with moderate to severe Alzheimer's disease.The company plans to conduct a multicenter, randomized, double-blind, placebo-
Discontinuation or exposure of Pfizer’s Ibrance (ingredient: palbociclib), the first CDK4/6 inhibitor, was not related to the drug’s failure to show additional benefit in combination with endocrine therapy in treating early breast cancer, a study showed.The study excluded the exposure of Ibrance fro
A local court has partially suspended the enforcement of the government's Covid-19 vaccine mandate.The vaccine pass program, which has been in effect since November, requires people to present proof of Covid-19 vaccination or negative test results when entering restaurants, cafes, and other multiuse
Sanofi said its interleukin-4/13 inhibitor Dupixent (dupilumab) aimed to treat chronic pruritus with high clinically unmet demand.On Tuesday, the Ministry of Food and Drug Safety allowed Sanofi to conduct a phase 3 trial of Dupixent.Sanofi plans to conduct two randomized, double-blind, placebo-contr
A research team at Yongin Severance Hospital found that the risk of developing ischemic heart disease significantly increases when the patient has early chronic kidney disease (CKD) accompanied by a fatty liver.A CKD and fatty liver with a fat content of more than 5 percent are representative diseas
inno.N disclosed a plan to develop a selective RET inhibitor targeted therapy, which the company acquired from Voronoi, a Korean new drug R&D company.On Wednesday, inno.N introduced four anticancer drug pipelines at the JP Morgan Healthcare Conference.The company said it completed a non-clinical tri
Celltrion said that Swissmedic, Switzerland’s drug administration, has temporary authorization for Regkirona (ingredient: regdanvimab).Celltrion submitted the results of large-scale global phase 3 clinical trials and preclinical data on various variants, including the Delta, to the Swissmedic, which
A doctor called for stopping the Covid-19 vaccination on Thursday, claiming she had found a “weird object” in a person inoculated with the Moderna vaccine.Earlier, the same doctor claimed that she found an “unidentified organism” in Covid-19 vaccines. Lee Young-mi, an obstetrician-gynecologist who m
Handok said that it began the exclusive sales of Mircera, Roche's chronic kidney disease anemia treatment, on Jan. 1.Mircera (ingredient name: methoxypolyethylene glycol-epoetin beta) is a third-generation erythrocyte hematopoietic stimulator to treat symptomatic anemia in patients with chronic kidn
Myongji Hospital is accelerating its efforts to become a biomedical hub hospital by enhancing advanced research and development in partnership with Bionsystems, a bio-drug developer.Under the business agreement, the two sides will promote joint R&D and technology exchange, support the commercializat